Back
Exxon Mobil Vs. Biomarin Pharmaceutical Industry Stock Comparison
Sell
44
XOM
Exxon Mobil
Last Price:
$109.72
Seasonality Move:
2.77%
Buy
60
BMRN
Biomarin Pharmaceutical
Last Price:
$63.83
Seasonality Move:
2.97%
Sell
44
Exxon Mobil (XOM)
is a Sell
Is Exxon Mobil a Buy, Sell or Hold?
-
The current Exxon Mobil [XOM] share price is $109.29. The Score for XOM is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
XOM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Biomarin Pharmaceutical (BMRN)
is a Buy
Is Biomarin Pharmaceutical a Buy, Sell or Hold?
-
The current Biomarin Pharmaceutical [BMRN] share price is $66.99. The Score for BMRN is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
XOM Stock Price Chart
What is Exxon Mobil's stock price today?
-
The Exxon Mobil share price today is $109.29The current trend is relatively stagnant and XOM is experiencing buying pressure, which is a positive indicator for future bullish movement.
BMRN Stock Price Chart
What is Biomarin Pharmaceutical's stock price today?
-
The Biomarin Pharmaceutical share price today is $66.99Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight buying pressure.
XOM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.69 | Sell |
Relative Strength Index (14 RSI): | 48.52 | Sell |
Chaikin Money Flow: | 12148373 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (105.93 - 111.37) | Buy |
Bollinger Bands (100): | (110.47 - 120.91) | Sell |
BMRN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.36 | Buy |
Relative Strength Index (14 RSI): | 52.34 | Buy |
Chaikin Money Flow: | 313204 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (65.62 - 67.3) | Buy |
Bollinger Bands (100): | (62.72 - 80.22) | Sell |
XOM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 107.75 | Buy |
20-day SMA: | 107.52 | Buy |
50-day SMA: | 113.88 | Sell |
200-day SMA: | 115.96 | Sell |
8-day EMA: | 107.73 | Buy |
20-day EMA: | 108.69 | Buy |
50-day EMA: | 112.08 | Sell |
200-day EMA: | 113.9 | Sell |
BMRN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 67.1 | Sell |
20-day SMA: | 66.47 | Buy |
50-day SMA: | 65.83 | Buy |
200-day SMA: | 77.73 | Sell |
8-day EMA: | 67.15 | Sell |
20-day EMA: | 66.66 | Buy |
50-day EMA: | 67.33 | Sell |
200-day EMA: | 75.78 | Sell |
Exxon Mobil Earnings Growth & XOM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and an increase next year of $1.31 per share.
Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.88 per share, and an increase next year of $1.02 per share.
Exxon Mobil Technical Analysis
Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Biomarin Pharmaceutical Technical Analysis
Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |